Dr. Benjamin A. Gartrell
Claim this profileMontefiore Medical Center-Einstein Campus
Expert in Prostate Cancer
Studies Bladder Cancer
16 reported clinical trials
33 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
metastatic
BRCA2
2Bladder Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Benjamin A. Gartrell is currently running
Long-Term Safety of AAA617
for Prostate Cancer
The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other AAA617 causally related serious adverse event(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials.
Recruiting3 awards Phase 4
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
More about Benjamin A. Gartrell
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Benjamin A. Gartrell has experience with
- Abiraterone Acetate
- Apalutamide
- Prednisone
- Cisplatin
- Gemcitabine
- Antiandrogen Therapy
Breakdown of trials Benjamin A. Gartrell has run
Prostate Cancer
Bladder Cancer
Renal Cell Carcinoma
Kidney Cancer
Transitional Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin A. Gartrell specialize in?
Benjamin A. Gartrell focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are metastatic.
Is Benjamin A. Gartrell currently recruiting for clinical trials?
Yes, Benjamin A. Gartrell is currently recruiting for 3 clinical trials in Bronx New York. If you're interested in participating, you should apply.
Are there any treatments that Benjamin A. Gartrell has studied deeply?
Yes, Benjamin A. Gartrell has studied treatments such as Abiraterone Acetate, Apalutamide, Prednisone.
What is the best way to schedule an appointment with Benjamin A. Gartrell?
Apply for one of the trials that Benjamin A. Gartrell is conducting.
What is the office address of Benjamin A. Gartrell?
The office of Benjamin A. Gartrell is located at: Montefiore Medical Center-Einstein Campus, Bronx, New York 10461 United States. This is the address for their practice at the Montefiore Medical Center-Einstein Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.